Pharming (PHAR) Total Debt (2019 - 2021)

Pharming's Total Debt history spans 3 years, with the latest figure at $165000.0 for Q4 2021.

  • Quarterly results put Total Debt at $165000.0 for Q4 2021, down 99.33% from a year ago — trailing twelve months through Dec 2021 was $165000.0 (down 99.33% YoY), and the annual figure for FY2021 was $165000.0, down 99.3%.
  • Total Debt for Q4 2021 was $165000.0 at Pharming, down from $24.5 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $38.9 million in Q4 2019 to a low of $165000.0 in Q4 2021.
  • The 3-year median for Total Debt is $24.5 million (2020), against an average of $21.2 million.
  • The sharpest move saw Total Debt tumbled 37.03% in 2020, then tumbled 99.33% in 2021.
  • Year by year, Total Debt stood at $38.9 million in 2019, then crashed by 37.03% to $24.5 million in 2020, then tumbled by 99.33% to $165000.0 in 2021.
  • According to Business Quant data, Total Debt over the past three periods came in at $165000.0, $24.5 million, and $38.9 million for Q4 2021, Q4 2020, and Q4 2019 respectively.